In the stock market, everything has to be seen in context. The most noticeable thing these past few days is that there is not much Gulf-rel...

In the April 2022-September 2024 bull market, every management appeared capable. Margins expanded, working capital looked manageable, capit...

What we are witnessing in the market these days is similar to scenarios that have played out in the past. There have been many points in th...

The Indian pharma sector made its initial global forays almost a quarter century ago. Companies sought out markets abroad, learnt to deal w...

What is evident in the last few trading sessions is how the street is treating Q4 earnings numbers. If a company delivers in terms of numbe...

The markets should be in a happy frame of mind till the time the current ceasefire in the Gulf region holds. Not many may like us using the...

Google is significantly expanding its presence in Bengaluru's Whitefield. The tech giant has secured rights for approximately 2.6 million s...

Piramal Enterprises Board approved the issuance of secured, rated, listed, and redeemable non-convertible debentures (NCDs) worth up to Rs ...

Larsen and Toubro (L&T) has overturned a Rs 702 crore customs duty demand following a favourable ruling from the Central Excise & Service T...

Aleor has product offerings across cream, gel, ointment, shampoo, lotion, solutions, sprays, foams, microsponge and nanoparticulate platfor...

Aleor Dermaceuticals has received final approval from the US Food and Drug Administration (USFDA) for its abbreviated new drug application ...

The futures and options contracts on these six securities would be available for trading with effect from February 26, the exchange said.

Quoting IQVIA data, Alembic Pharma said Amantadine Hydrochloride Tablets, 100 mg have an estimated market size of USD 13 million for twelve...

“Only business houses that have mastered the art of succession planning, and those that have instilled family values among young inheritors...

Alembic Pharma manufactures and markets generic pharmaceutical products across the globe.

"APL and Orbicular will own 60 per cent and 40 per cent of the equity capital of Aleor when the transaction is completed," the Vadodara-bas...

Alembic today said it has signed $11 million licensing agreement with Belgium-based UCB for anti-epileptic drug Keppra.